EUVIMEDEUVIMED entdecken
Fallbericht

Medication‐related osteonecrosis of the jaw in an older patient with multiple myeloma

Larissa Couto de Freitas, Vanessa Silvestre de Aquino Silva, Marta Miyazawa iD, Carine Ervolino de Oliveira iD, Felipe Fornias Sperandio iD, João Adolfo Costa Hanemann iD

Gerodontology · 2025

DOI: 10.1111/ger.12758 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Gerodontology, 2025. Verfasst von Larissa Couto de Freitas und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Dentistry, Federal University of Alfenas, Alfenas, Minas Gerais, Brazil. Hauptthemen laut MEDLINE: Multiple Myeloma, Bisphosphonate-Associated Osteonecrosis of the Jaw, Bone Density Conservation Agents, Diphosphonates. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Conselho Nacional de Desenvolvimento Científico e Tecnológico.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This article reports a case of medication‐related osteonecrosis of the jaw (MRONJ) associated with multiple myeloma (MM).

Background

Bisphosphonates (BPs) are constantly used as part of the treatment for MM. The main adverse effects of bisphosphonates are renal insufficiency and medication‐related osteonecrosis of the jaw (MRONJ). Materials and Methods A 67‐year‐old female with a previous diagnosis of MM and undergoing current receiving intravenous injections of pamidronate underwent a tooth extraction and subsequently developed MRONJ.

Results

MRONJ was managed with clindamycin, surgical removal of bony sequestrum and curettage. At 3 years of follow‐up, the patient was asymptomatic with no clinical changes and panoramic radiography without evidence of recurrence.

Conclusion

Management of patients under antiresorptive drugs who require invasive dental procedures is challenging. Therefore, interprofessional collaboration, especially between the general practitioner and oncologist and/or haematologist, is essential to reach the best clinical approach and reduce the risk of MRONJ.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple MyelomaBisphosphonate-Associated Osteonecrosis of the JawBone Density Conservation AgentsDiphosphonatesHumansFemaleAgedPamidronateRadiography, PanoramicTooth Extraction

Stichwörter der Autor:innen

bisphosphonatesmedication‐related osteonecrosis of the jawmultiple myeloma

Substanzen

PamidronateBone Density Conservation AgentsDiphosphonates

Autor:innen und Institutionen

  • School of Dentistry, Federal University of Alfenas, Alfenas, Minas Gerais, Brazil.
  • Departament of Pathology and Parasitology, Biomedical Science Institute, Federal University of Alfenas, Alfenas, Minas Gerais, Brazil.
  • College of Dentistry, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.

ORCID-Profile: Marta Miyazawa, Carine Ervolino de Oliveira, Felipe Fornias Sperandio, João Adolfo Costa Hanemann

Förderung

  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico

Zitieren

APA

de Freitas, L. C., de Aquino Silva, V. S., Miyazawa, M., de Oliveira, C. E., Sperandio, F. F., & Hanemann, J. A. C. (2025). Medication‐related osteonecrosis of the jaw in an older patient with multiple myeloma. Gerodontology. https://doi.org/10.1111/ger.12758

Vancouver

de Freitas LC, de Aquino Silva VS, Miyazawa M, de Oliveira CE, Sperandio FF, Hanemann JAC. Medication‐related osteonecrosis of the jaw in an older patient with multiple myeloma. Gerodontology. 2025. doi:10.1111/ger.12758

BibTeX
@article{deFreitas2025,
  author = {de Freitas, Larissa Couto and de Aquino Silva, Vanessa Silvestre and Miyazawa, Marta and de Oliveira, Carine Ervolino and Sperandio, Felipe Fornias and Hanemann, João Adolfo Costa},
  title = {Medication‐related osteonecrosis of the jaw in an older patient with multiple myeloma},
  journal = {Gerodontology},
  year = {2025},
  doi = {10.1111/ger.12758}
}
Kostenlos starten →